Bioprofile analysis: A new approach for the analysis of biomedical data in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 32, Issue 4, 2012, Pages 997-1010

  Escudero, Javier ^a   Ifeachor, Emmanuel ^a   Zajicek, John P ^b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Alzheimer's disease; Bioindex; biomarkers; Bioprofile; machine learning; mild cognitive impairment; unsupervised techniques

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BIOMEDICINE; DATA BASE; DISEASE COURSE; EVOLUTION; HEALTH CARE PERSONNEL; HUMAN; HYPOTHESIS; MILD COGNITIVE IMPAIRMENT; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 84872282803     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121024     Document Type: Article

References (38)

1. Hu P, Sun L, Ifeachor E (2009) A Framework for Bioprofile Analysis Over Grid. IEEE Sys J 3, 520-535.
2. Wimo A, PrinceM(2010)World Alzheimer Report 2010: The global economic impact of dementia. Alzheimer's Disease International.
3. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403.
4. Chen K, Ayutyanont N, Langbaum JBS, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM (2011) Characterizing Alzheimer's disease using a hypometabolic convergence index. NeuroImage 56, 52-60.
5. Cuingnet R, Gerardin E, Tessieras J, Auzias G, Leh́ericy S, Habert M-O, Chupin M, Benali H, Colliot O (2011) Automatic classification of patients with Alzheimer's disease from structural MRI:Acomparison of ten methods using the ADNI database. NeuroImage 56, 766-781.
6. Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.
7. Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM, the Alzheimer's Disease Neuroimaging Initiative (2009) Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad SciUS A 106, 20954-20959.
8. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32, 1207-1218.
9. Nordberg A, Rinne JO, Kadir A, Langstrom B (2010) The use of PET in Alzheimer disease. Nat Rev Neurol 6, 78-87.
10. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM-Y, Trojanowski JQ (2009) Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann Neurol 65, 403-413.
11. Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, Holtzman DM (2009) Decreased CSF A-42 correlates with brain atrophy in cognitively normal elderly. Ann Neurol 65, 176-183.
12. Hornero R, Ab́asolo D, Escudero J, Ǵomez C (2009) Nonlinear analysis of electroencephalogram and magnetoencephalogram recordings in patients with Alzheimer's disease. Philos Trans R Soc A-Math Phys Eng Sci 367, 317-336.
13. Babiloni C, Vecchio F, Lizio R, Ferri R, Rodriguez G, Marzano N, Frisoni GB, Rossini PM (2011) Resting state cortical rhythms in mild cognitive impairment and Alzheimer's disease: Electroencephalographic evidence. J Alzheimers Dis 26, 201-214.
14. Drago V, Babiloni C, Bartŕes-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki H-W, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, H°ardemark H, Frisoni GB (2011) Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. J Alzheimers Dis 26(Suppl 3), 159-199.
15. Escudero J, Sanei S, Jarchi D, Ab́asolo D, Hornero R (2011) Regional coherence evaluation in mild cognitive impairment and Alzheimer's disease based on adaptively extracted magnetoencephalogram rhythms. Physiol Meas 32, 1163-1180.
16. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ (2012) The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement 8, S1-S68.
17. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
18. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
19. Caroli A, Frisoni GB (2010) The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiol Aging 31, 1263-1274.
20. Yang E, Farnum M, Lobanov V, Schultz T, Raghavan N, Samtani MN, Novak G, Narayan V, Dibernardo A (2011) Quantifying the pathophysiological timeline of Alzheimer's disease. J Alzheimers Dis 26, 745-753.
21. Witten IH, Frank E, Hall MA (2011) Data Mining: Practical Machine Learning Tools and Techniques, Elsevier.
22. Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, deToledo-MorrellL(2011) Alzheimer-signature MRI biomarker predictsADdementia in cognitively normal adults. Neurology 76, 1395-1402.
23. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL (2009) The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19, 497-510.
24. Bakkour A, Morris JC, Dickerson BC (2009) The cortical signature of prodromal AD. Neurology 72, 1048-1055.
25. Fan Y, Batmanghelich N, Clark CM, Davatzikos C (2008) Spatial patterns of brain atrophy inMCIpatients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. NeuroImage 39, 1731-1743.
26. Llano DA, Laforet G, Devanarayan V (2011) Derivation of a new ADAS-cog composite using tree-based multivariate analysis. Alzheimer Dis Assoc Dis 25, 73-84.
27. Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, Soininen H, L̈otj̈onen J (2011) A disease state fingerprint for evaluation of Alzheimer's disease. J Alzheimers Dis 27, 163-176.
28. Xu R, Wunsch DC (2010) Clustering algorithms in biomedical research: A review. IEEE Rev Biomed Eng 3, 1-35.
29. Nettiksimmons J, Harvey D, Brewer J, Carmichael O, DeCarli C, Jack CR Jr, Petersen R, Shaw LM, Trojanowski JQ, Weiner MW, Beckett L (2010) Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiol Aging 31, 1419-1428.
30. De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ, for the Alzheimer's Disease Neuroimaging Initiative (2010) Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 67, 949-956.
31. Escudero J, Zajicek JP, Ifeachor E, The Alzheimer's Disease Neuroimaging Initiative (2011) Early detection and characterization of Alzheimer's disease in clinical scenarios using Bioprofile concepts and k-means. In Proc 33rd Ann Int Conf IEEE Eng Med Biol Soc IEEE EMBC2011, Boston, MA, USA, pp. 6470-6473.
32. Filipovych R, Davatzikos C (2011) Semi-supervised pattern classification of medical images: Application to mild cognitive impairment (MCI). NeuroImage 55, 1109-1119.
33. Hartigan JA, Wong MA (1979) A k-means clustering algorithm. J R Stat Soc Ser C 28, 100-108.
34. Haller S, Lovblad KO, Giannakopoulos P (2011) Principles of classification analyses in mild cognitive impairment (MCI) and Alzheimer disease. J Alzheimers Dis 26(Suppl 3), 389-394.
35. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, Bullido MJ, Engelborghs S, Deyn PD, Berr C, Pasquier F, Dubois B, Tognoni G, Fíevet N, Brouwers N, Bettens K, Arosio B, Coto E, Zompo MD, Mateo I, Epelbaum J, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Valdivieso F, Vepsalainen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Hanon O, Piccardi P, Annoni G, Seripa D, Galimberti D, Licastro F, Soininen H, Dartigues J-F, Kamboh MI, Broeckhoven CV, Lambert JC, Amouyel P, Campion D (2011) APOE and Alzheimer disease: A major gene with semi-dominant inheritance. Mol Psychiatr 16, 903-907.
36. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
37. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
38. Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 257-262.